WMT AG
General information
WMT AG
Waldhofer Str. 104
69123 Heidelberg, Baden-Württemberg
Germany
Contact person: Claus Kremoser, Chief Executive Officer
Company main phone: +49 (6221) 65282-0
Website: https://wm-therapeutics.com/
Waldhofer Str. 104
69123 Heidelberg, Baden-Württemberg
Germany
Contact person: Claus Kremoser, Chief Executive Officer
Company main phone: +49 (6221) 65282-0
Website: https://wm-therapeutics.com/
| Year founded: | 2020 |
| Source of foundation: | Independent foundation |
Corporate description / mission:
WMT develops small molecules to treat late-stage solid cancers. The company targets the so-called Warburg metabolism, i.e. the high rate of glycolysis and lactate production that is adopted by late-stage tumors. Applying anti-Warburg Warheads (AWWs) dim down this specific form of cancer metabolism, thereby lowering the lactate in the tumor microenvironment. As a result, achieve inhibition of tumor growth as such as well as re-stimulation of the immune system against the solid tumor.
WMT develops small molecules to treat late-stage solid cancers. The company targets the so-called Warburg metabolism, i.e. the high rate of glycolysis and lactate production that is adopted by late-stage tumors. Applying anti-Warburg Warheads (AWWs) dim down this specific form of cancer metabolism, thereby lowering the lactate in the tumor microenvironment. As a result, achieve inhibition of tumor growth as such as well as re-stimulation of the immune system against the solid tumor.
State of ownership: Private / independent
Headquarters: Yes
Headquarters: Yes
Categorization
| Sector: |
|
| Subsector: |
|
| Primary therapeutic areas: |
|
| Business model: |
|
| Customer segments: |
|
Summary Products / Services / Technologies
Number of Biotech Products
| Pre-clinical: | 1 |
© 2023 Biotechgate by Venture Valuation